13 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:04am
for this spending, taxes may need to be raised while health care budgets may be restrained. This could accelerate downward pressure on drug pricing. Recent
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
31 May 22
Current report (foreign)
6:14am
of abating. This perfect storm scenario will have an impact on investment in innovation and could accelerate downward pressure on drug pricing. While
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:19am
, if governments can demonstrate improved efficiency and effectiveness in health care systems, the investment is more readily justifiable. The restrictive drug … pricing and reimbursement policies adopted in the EU and the U.K., coupled with persistent price reductions in Japan, raise concerns about the impact
6-K
TAK
Takeda Pharmaceutical Co
11 May 23
Current report (foreign)
6:07am
. At the same time, unpredictable and escalating payment rates under the U.K.’s drug pricing and reimbursement scheme raise concerns about the impact
6-K
TAK
Takeda Pharmaceutical Co
13 Feb 20
Current report (foreign)
6:05am
products business and the generics business, due to the changes in the business environment such as the Drug Pricing Reform.
- 33 -
8. Income Tax
6-K
wwr4jpah6d1ipf3w
12 Feb 21
Current report (foreign)
6:04am
6-K
EX-99.1
aslvu ireip
6 Jul 23
Current report (foreign)
6:18am
20FR12B/A
icf njukglhtcro7e
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
DRS/A
gyr5s9
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B
gzsr64g5ue0n3xu k4cn
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
6-K
EX-99.1
h0iwps2o1d
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
p45wsi3gz06
30 May 23
Current report (foreign)
6:11am
- Prev
- 1
- Next